Stock Details
GILD is Gilead Sciences, Inc.'s stock. Stock exchange NasdaqGS (Currency USD). Average price in 50 days is 82.37$. Average daily volumn in 3 months 6.24M. Market cap 101.04B

Stock symbol : GILD. Exchange : NasdaqGS. Currency : USD
Lastest price : 80.90$. Total volume : 1.30M. Market state REGULAR
Click reload if you want to check the lastest price on market!!!

Gilead Sciences, Inc. (GILD)
Last Price

Previous Close79.58
Day Range79.79-80.94
Bid80.82 x 800
Ask80.83 x 1k
Average Volume6.24M
Market Cap101.04B
52 Week Range57.17-89.74
Trailing P/E22.23
Foward P/E11.21
Dividend (Yield %)3.77%
Ex-Dividend Date2023-03-14

Financial Details

According to Gilead Sciences, Inc.'s financial reports the company's revenue in 2022 were 27.28B an decrease(0%) over the years 2021 revenue that were of 27.3B. In 2022 the company's total earnings were 4.59B while total earnings in 2021 were 6.22B(-33.33%).

Loading ...


Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of vi... ral hepatitis. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Merck & Co, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.

Market Cap:
Total Assets:
Total Cash:

News about "Gilead Sciences, Inc."

Gilead Sciences Inc. (GILD) Stock: What the Analysts are Saying

Source from : newsheater - 5 days ago

Gilead Sciences Inc. (NASDAQ: GILD) has a price-to-earnings ratio that is above its average at 21.65x. and a 36-month beta value of 0.40. Opinions on the stock are mixed, with 9 analysts rating it as ...See details»

gilead sciences inc.

Source from : Fox Business - 5 days ago

Pfizer and its rivals, including U.S.-based Merck & Co Inc and Swiss pharmaceutical Roche Holding AG are racing to produce the first antiviral pill that people could take at early signs of the ...See details»


Gilead (GILD) Exercises Option to License Nurix's Candidate

Source from : YAHOO!Finance - 7 days ago

Gilead (GILD) exercises an option under its collaboration agreement with Nurix to license the latter???s investigational targeted protein degrader molecule NX 0479.See details»


Gilead Sciences Inc. stock rises Thursday, still underperforms market

Source from : MarketWatch - 12 days ago

Shares of Gilead Sciences Inc. inched 0.25% higher to $79.85 Thursday, on what proved to be an all-around great trading session for the stock market, ...See details»

Gilead Sciences Inc. (GILD) Has Recovered 26.05% From Its Low: Is This The Beginning Of A Trend?

Source from : stocksregister - 11 days ago

Gilead Sciences Inc. (NASDAQ:GILD) price on Friday, March 17, fall -3.18% below its previous dayโ€™s close as a downside momentum from buyers pushed the stockโ€™s value to $77.31. A look at the stockโ€™s ...See details»

Gilead Sciences Inc. (GILD) Stock: A Guide to the Market Trend

Source from : newsheater - 7 days ago

The stock of Gilead Sciences Inc. (GILD) has seen a -0.06% decrease in the past week, with a -4.71% drop in the past month, and a -8.22% decrease in the past quarter. The volatility ratio for the week ...See details»

Gilead Sciences, Inc. (NASDAQ:GILD) is a favorite amongst institutional investors who own 84%

Source from : Yahoo Finance - 16 days ago

We note that hedge funds don't have a meaningful investment in Gilead Sciences. BlackRock, Inc. is currently the company's largest shareholder with 11% of shares outstanding. For context ...See details»

Gilead Sciences Announces $3 Million in Grant Funding to Eight Organizations Addressing HIV Disparities in Rural U.S. Communities

Source from : Stockhouse - 6 days ago

s Zeroing Inโ„ข: Ending the HIV Epidemic Grant Program โ€“ Gilead Sciences, Inc. (Nasdaq: GILD) today announced it is providing a total of $3 million in grant funding to eight organizations to provide ...See details»

Gilead Sciences must pay $1.8 million in attorney fees and costs after denying shareholders access to records

Source from : Courthouse News Service - 1 year ago

The Gilead Sciences headquarters in Foster City, Calif., in April 2020. (AP Photo/Ben Margot, File) (CN) โ€” A Delaware court on Thursday ordered Gilead Sciences Inc. to pay nearly $1.8 million in ...See details»

Gilead Presents New Data From HIV Cure Research Program and Collaborations Exploring Novel Investigational Combinations and Strategies

Source from : Stockhouse - 1 month ago

Gilead Sciences, Inc. (Nasdaq: GILD) today announced results from four collaborative studies evaluating novel investigational combinations and strategies with the potential to target the HIV viral ...See details»

Gilead Sciences, Inc.

Source from : Fierce Healthcare - 1 month ago

For 35 years, Gilead has been a leading innovator in the field of HIV, driving advances in treatment, prevention and cure research. Gilead researchers have developed 12 HIV medications ...See details»

Gilead Sciences Inc. stock rises Tuesday, still underperforms market

Source from : MarketWatch - 13 days ago

Shares of Gilead Sciences Inc. GILD rallied 1.28% to $79.77 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 1.68% to 3,920 ...See details»

Gilead Sciences Inc

Source from : Reuters - 13 days ago

2023 Future of Healthcategory GSK's ViiV says study shows its long-acting HIV shot as effective as Gilead's daily pill, article with image February 22, 2023 Worldcategory Britain's NICE to speed ...See details»

GILD Gilead Sciences, Inc.

Source from : Seeking Alpha - 5 days ago

**NM signifies a non meaningful value. A dash signifies the data is not available.See details»